NASHVILLE, Tenn. / Jan 04, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 4Q Earnings Release Call |
When: | Tuesday, January 30, 2024 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$381.39 |
| Daily Change: | 2.74 0.72 |
| Daily Volume: | 2,095,552 |
| Market Cap: | US$96.610B |
April 25, 2025 February 20, 2025 February 18, 2025 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
